Penn State research-based startup works toward helping to treat diabetic wounds
https://psu-gatsby-files-prod.s3.amazonaws.com/s3fs-public/styles/4_3_2000w/public/2022/06/Elkos Rx 597x500 IPS Site.png?h=07d74d6d&itok=0wAxxCjz
People with both Type 1 and Type 2 diabetes often experience suppressed wound healing. Penn State research-based startup ElkosRx is working to bring its topical treatment for early-stage diabetic foot ulcers to the market.